GW Pharma surges on new epilepsy trial successUK-based GW Pharmaceuticals surged ahead on the stock market after it announced its cannabis-based drug Epidiolex had succeeded Share XGW Pharma surges on new epilepsy trial successhttps://pharmaphorum.com/news/gw-pharma-surges-on-new-epilepsy-trial-success/
